MutS homolog 6 (Msh6) is a key component of the mismatch repair (MMR) system, a crucial cellular mechanism responsible for maintaining genomic integrity by identifying and correcting base-pair mismatches that occur during DNA replication and recombination. Msh6, in partnership with Msh2, forms the heterodimer Msh2-Msh6, also known as MutSα, which specifically recognizes and binds to base mismatches and insertion-deletion loops (IDLs) in the DNA. The recognition of these mismatches is the first step in a highly coordinated process that leads to the repair of the erroneous bases, ensuring the fidelity of DNA replication and preventing the accumulation of mutations that could lead to genomic instability and disease. The Msh2-Msh6 complex plays a vital role in the cellular defense against mutagenesis by activating a cascade of events that include mismatch recognition, recruitment of repair proteins, and eventual correction of the mismatch, thereby upholding the integrity of the genome.
The activation of Msh6 and its function within the MMR pathway is intricately linked to its interaction with Msh2 and the subsequent binding to DNA mismatches. This activation process begins with the detection of a mismatch by the MutSα complex, which undergoes a conformational change upon binding to the DNA error. This change is critical for the recruitment and activation of other MMR proteins, including exonucleases, DNA helicases, and DNA polymerases, which collectively participate in the excision and resynthesis of the incorrect DNA segment. The ATPase activity of the Msh2-Msh6 complex is central to its function; ATP binding and hydrolysis are required for the initiation of the repair process and for the dissociation of MutSα from DNA after the repair is complete. This ensures that the repair machinery is correctly targeted to the site of the mismatch and that the process is efficiently concluded, allowing the repair complex to reset and be ready for subsequent rounds of mismatch repair. The precise regulation of Msh6 and its interaction with other MMR components underscore the sophisticated nature of the cellular mechanisms designed to preserve genomic stability through the accurate correction of DNA replication errors.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
A PARP inhibitor, Olaparib can influence DNA repair pathways, potentially affecting MSH6 activity in response to DNA damage. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
Another PARP inhibitor, Niraparib may indirectly impact MSH6 activity by modulating DNA repair processes. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
As a PARP inhibitor, Rucaparib can affect DNA repair mechanisms, potentially impacting MSH6 function. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Similar to Cisplatin, Oxaliplatin induces DNA crosslinks, potentially impacting MSH6 function in DNA repair. | ||||||